PK/PD of Digoxin in Infants With SVHD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PK/PD of Digoxin in Infants With SVHD — Stella

Home/Single-ventricle/

View on ClinicalTrials.gov

Recruiting

Back to Single-ventricle trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United States

Duke University Medical Center, Durham, North Carolina

Medical University of South Carolina, Charleston, South Carolina

Key details

Phase

Early testing / Safety & dosing

Sponsor

Duke University

Collaborators

Medical University of South Carolina, Duke Clinical Research Institute

Enrollment target

~20 participants

Started

October 2024

Primary completion

November 2026

Age range

30 Days – 6 Months

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.